HG-1051

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1051

Drug Alias Name4-1BB ligand receptor modulator (Human Genome Sciences)4-1BB modulator (Human Genome Sciences)CD137 antigen modulator (Human Genome Sciences)ILA modulator (Human Genome Sciences)MGC2172 modulator (Human Genome Sciences) +[16]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 modulators

TargetsTumor necrosis factor receptor superfamily member 9

Therapy Area/IndicationsInflammationImmune System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A